Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators
Anna Giulia Pavon, Alessandra Pia Porretta, Dimitri Arangalage, Giulia Domenichini, Tobias Rutz, Sarah Hugelshofer, Etienne Pruvot, Pierre Monney, Patrizio Pascale, Juerg Schwitter, Anna Giulia Pavon, Alessandra Pia Porretta, Dimitri Arangalage, Giulia Domenichini, Tobias Rutz, Sarah Hugelshofer, Etienne Pruvot, Pierre Monney, Patrizio Pascale, Juerg Schwitter
Abstract
Background: The use of stress perfusion-cardiovascular magnetic resonance (CMR) imaging remains limited in patients with implantable devices. The primary goal of the study was to assess the safety, image quality, and the diagnostic value of stress perfusion-CMR in patients with MR-conditional transvenous permanent pacemakers (PPM) or implantable cardioverter-defibrillators (ICD).
Methods: Consecutive patients with a transvenous PPM or ICD referred for adenosine stress-CMR were enrolled in this single-center longitudinal study. The CMR protocol was performed using a 1.5 T system according to current guidelines while all devices were put in MR-mode. Quality of cine, late-gadolinium-enhancement (LGE), and stress perfusion sequences were assessed. An ischemia burden of ≥ 1.5 segments was considered significant. We assessed the safety, image quality and the occurrence of interference of the magnetic field with the implantable device. In case of ischemia, we also assessed the correlation with the presence of significant coronary lesions on coronary angiography.
Results: Among 3743 perfusion-CMR examinations, 66 patients had implantable devices (1.7%). Image quality proved diagnostic in 98% of cases. No device damage or malfunction was reported immediately and at 1 year. Fifty patients were continuously paced during CMR. Heart rate and systolic blood pressure remained unchanged during adenosine stress, while diastolic blood pressure decreased (p = 0.007). Six patients (9%) had an ischemia-positive stress CMR and significant coronary stenoses were confirmed by coronary angiography in all cases.
Conclusion: Stress perfusion-CMR is safe, allows reliable ischemia detection, and provides good diagnostic value.
Keywords: Adenosine; Cardiovascular magnetic resonance; Implantable cardioverter defibrillator; Implantable device; MRI conditional; Pacemaker; Safety; Stress test.
Conflict of interest statement
Beyond the study’s interests, Prof Schwitter received research grants from Bayer Healthcare, Switzerland. Other authors have nothing to disclose.
© 2021. The Author(s).
Figures
References
- Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ. AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 doi: 10.1161/CIR.0000000000001030.
- Saraste A, Knuuti J. ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: recommendations for cardiovascular imaging. Herz. 2020;45(5):409–420. doi: 10.1007/s00059-020-04935-x.
- Stanton MS. Industry viewpoint: medtronic: pacemakers, ICDs, and MRI. Pacing Clin Electrophysiol. 2005;28(4):265. doi: 10.1111/j.1540-8159.2005.50025.x.
- European Society of C. European Heart Rhythm A. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Europace. 2013;15(8):1070–118. doi: 10.1093/europace/eut206.
- Schwitter J, Kanal E, Schmitt M, Anselme F, Albert T, Hayes DL, et al. Impact of the Advisa MRI pacing system on the diagnostic quality of cardiac MR images and contraction patterns of cardiac muscle during scans: Advisa MRI randomized clinical multicenter study results. Heart Rhythm. 2013;10(6):864–872. doi: 10.1016/j.hrthm.2013.02.019.
- Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace. 2008;10(3):336–346. doi: 10.1093/europace/eun021.
- Schwitter J, Gold MR, Al Fagih A, Lee S, Peterson M, Ciuffo A, et al. Image quality of cardiac magnetic resonance imaging in patients with an implantable cardioverter defibrillator system designed for the magnetic resonance imaging environment. Circ Cardiovasc Imaging. 2016 doi: 10.1161/CIRCIMAGING.115.004025.
- Gold MR, Sommer T, Schwitter J, Al Fagih A, Albert T, Merkely B, et al. Full-body MRI in patients with an implantable cardioverter-defibrillator: primary results of a randomized study. J Am Coll Cardiol. 2015;65(24):2581–2588. doi: 10.1016/j.jacc.2015.04.047.
- Gimbel JR, Bello D, Schmitt M, Merkely B, Schwitter J, Hayes DL, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm. 2013;10(5):685–91. doi: 10.1016/j.hrthm.2013.01.022.
- Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14(7):e97–e153. doi: 10.1016/j.hrthm.2017.04.025.
- Klein-Wiele O, Garmer M, Urbien R, Busch M, Kara K, Mateiescu S, et al. Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla. J Cardiovasc Magn Reson. 2015;17:112. doi: 10.1186/s12968-015-0218-x.
- Klein-Wiele O, Garmer M, Busch M, Mateiescu S, Urbien R, Barbone G, et al. Cardiovascular magnetic resonance in patients with magnetic resonance conditional pacemaker systems at 1.5 T: influence of pacemaker related artifacts on image quality including first pass perfusion, aortic and mitral valve assessment, flow measurement, short tau inversion recovery and T1-weighted imaging. Int J Cardiovasc Imaging. 2017;33(3):383–94. doi: 10.1007/s10554-016-1012-z.
- Klein-Wiele O, Garmer M, Barbone G, Urbien R, Busch M, Kara K, et al. Deactivation vs. asynchronous pacing—prospective evaluation of a protocol for rhythm management in patients with magnetic resonance conditional pacemakers undergoing adenosine stress cardiovascular magnetic resonance imaging. BMC Cardiovasc Disord. 2017;17(1):142. doi: 10.1186/s12872-017-0579-1.
- Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29(4):480–489. doi: 10.1093/eurheartj/ehm617.
- Klinke V, Muzzarelli S, Lauriers N, Locca D, Vincenti G, Monney P, et al. Quality assessment of cardiovascular magnetic resonance in the setting of the European CMR registry: description and validation of standardized criteria. J Cardiovasc Magn Reson. 2013;15:55. doi: 10.1186/1532-429X-15-55.
- Vincenti G, Masci PG, Monney P, Rutz T, Hugelshofer S, Gaxherri M, et al. Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization. JACC Cardiovasc Imaging. 2017;10(5):526–537. doi: 10.1016/j.jcmg.2017.02.006.
- Plein S, Schulz-Menger J, Almeida A, Mahrholdt H, Rademakers F, Pennell D, et al. Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology. Eur Heart J. 2011;32(7):793–798. doi: 10.1093/eurheartj/ehq474.
- Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002;18(1):539–42.
- Schwitter JlM. Coronary artery disease; ischemia–perfusion. 2020.
- Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, et al. Splenic switch-off: a tool to assess stress adequacy in adenosine perfusion cardiac MR imaging. Radiology. 2015;276(3):732–740. doi: 10.1148/radiol.2015142059.
- Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C. European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging. 2019;20(12):1321–1331. 10.1093/ehjci/jez232. Erratum in: Eur Heart J Cardiovasc Imaging. 2019;20(12):1331.
- Hilbert S, Jahnke C, Loebe S, Oebel S, Weber A, Spampinato R, et al. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: a device-dependent imaging strategy for improved image quality. Eur Heart J Cardiovasc Imaging. 2018;19(9):1051–1061. doi: 10.1093/ehjci/jex243.
- Gold MR, Sommer T, Schwitter J, Kanal E, Bernabei MA, Love CJ, et al. Impact of magnetic resonance imaging on ventricular tachyarrhythmia sensing: results of the Evera MRI Study. Heart Rhythm. 2016;13(8):1631–1635. doi: 10.1016/j.hrthm.2016.05.014.
Source: PubMed